|
Volumn 27 Suppl 2, Issue , 2000, Pages 498-504
|
Preliminary results of multicenter phase II trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CORTICOSTEROID;
DOCETAXEL;
DOXORUBICIN;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
ADULT;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
FEMALE;
HEART LEFT VENTRICLE FUNCTION;
HEART STROKE VOLUME;
HUMAN;
INDONESIA;
LIVER TUMOR;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
ADRENAL CORTEX HORMONES;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INDONESIA;
LIVER NEOPLASMS;
MIDDLE AGED;
PACLITAXEL;
REMISSION INDUCTION;
STROKE VOLUME;
TAXOIDS;
VENTRICULAR FUNCTION, LEFT;
|
EID: 0038023695
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|